A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The trial will test the equivalence of a repeat bolus protocol of magnesium sulfate
administered by the Springfusor® controlled pump to a continuous intravenous regimen. The
goal of this pharmacokinetic study is to assess the pharmacological equivalence of the serum
magnesium sulfate concentrations obtained in the treatment of severe preeclampsia with the
continuous intravenous and Springfusor repeat bolus regimens. The study will also document
the clinical outcomes, efficacy and acceptability of each treatment for patients and staff.